Insider Transactions in Q4 2025 at Acrivon Therapeutics, Inc. (ACRV)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.96%
|
$39,808
$2.3 P/Share
|
|
Nov 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.93%
|
$1,226
$2.24 P/Share
|
|
Nov 14
2025
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-2.57%
|
$806
$2.24 P/Share
|
|
Nov 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.53%
|
$368
$2.24 P/Share
|
|
Nov 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-2.35%
|
$198
$2.24 P/Share
|
|
Nov 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
490
-0.16%
|
$980
$2.24 P/Share
|
|
Nov 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,765
-2.81%
|
$119,530
$2.24 P/Share
|
|
Oct 17
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.58%
|
$558
$1.81 P/Share
|
|
Oct 01
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-0.8%
|
$284
$1.81 P/Share
|